RE: Another day closer to the big news6 Jul 2021 10:41
News this week, looking forward "The mechanism of actions of AZD1656, both blood glucose lowering and potential immunomodulatory action, are independent of viral mutations. AZD1656 activates glucokinase, which is expected to increase the migration of T regulatory cells in addition to reducing blood glucose. Reducing hyperglycaemia (high blood glucose) is increasingly seen to be important to improve outcomes in people with diabetes and COVID-19. Migration of regulatory T cells is expected to dampen down the hyperinflammation seen in the lungs, for instance, that results in severe COVID-19. "Positive news this will follow Sar's mcap not mcap of around £250m not measily 11m enormous appreciation in front os us IMO 2p plus £100m plus...